Citation: Xy. Zhou et Ed. Frohlich, Functional and structural involvement of afferent and efferent glomerular arterioles in hypertension, AM J KIDNEY, 37(5), 2001, pp. 1092-1094
Citation: J. Diez et Ed. Frohlich, Fourth International Seminar on Cardiovascular Biology and Medicine: Part I, HYPERTENSIO, 38(5), 2001, pp. 1198-1198
Authors:
Jones, DW
Frohlich, ED
Grim, CM
Grim, CE
Taubert, KA
Citation: Dw. Jones et al., Response to the advisory statement from the Council for High Blood Pressure Research of the American Heart Association advocating retention of mercury sphygmomanometers - Response, HYPERTENSIO, 38(4), 2001, pp. E20-E20
Citation: J. Varagic et al., Coronary hemodynamic and ventricular responses to angiotensin type 1 receptor inhibition in SHR - Interaction with angiotensin type 2 receptors, HYPERTENSIO, 37(6), 2001, pp. 1399-1403
Citation: Y. Nakamura et al., Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N-omega-nitro-L-arginine methyl ester/spontaneously hypertensive rats, HYPERTENSIO, 37(5), 2001, pp. 1262-1267
Citation: D. Susic et al., Abnormal renal vascular responses to dipyridamole-induced vasodilation in spontaneously hypertensive rats, HYPERTENSIO, 37(3), 2001, pp. 894-897
Authors:
Jones, DW
Frohlich, ED
Grim, CM
Grim, CE
Taubert, KA
Citation: Dw. Jones et al., Mercury sphygmomanometers should not be abandoned: An advisory statement from the council for high blood pressure research, American Heart Association, HYPERTENSIO, 37(2), 2001, pp. 185-186